GLP-1 drugs (e.g., Ozempic, Mounjaro), primarily used for type 2 diabetes and weight loss, can have several implications for potential orthopedic patients, particularly through their effects on weight reduction and metabolic health. While the article "Longevity’s First Blockbuster" doesn’t directly address orthopedic outcomes, I’ll synthesize relevant effects based on their mechanism and broader medical knowledge, focusing on how they might influence individuals at risk for or managing orthopedic conditions.
Positive Effects for Orthopedic Patients
Weight Loss and Reduced Joint Stress:
GLP-1...
The Orthopedics Industry 
